ID   KAPCA_RAT               Reviewed;         351 AA.
AC   P27791; Q6UA68;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   02-OCT-2024, entry version 206.
DE   RecName: Full=cAMP-dependent protein kinase catalytic subunit alpha;
DE            Short=PKA C-alpha;
DE            EC=2.7.11.11;
GN   Name=Prkaca;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=1711374; DOI=10.1016/0167-4781(91)90018-h;
RA   Wiemann S., Voss H., Kinzel V., Pyerin W.;
RT   "Rat C alpha catalytic subunit of the cAMP-dependent protein kinase: cDNA
RT   sequence and evidence that it is the only isoform expressed in myoblasts.";
RL   Biochim. Biophys. Acta 1089:254-256(1991).
RN   [2]
RP   PROTEIN SEQUENCE OF 2-8 (ISOFORM 1), MYRISTOYLATION AT GLY-2, AND
RP   DEAMIDATION AT ASN-3.
RX   PubMed=9521123; DOI=10.1002/pro.5560070227;
RA   Jedrzejewski P.T., Girod A., Tholey A., Koenig N., Thullner S., Kinzel V.,
RA   Bossemeyer D.;
RT   "A conserved deamidation site at Asn 2 in the catalytic subunit of
RT   mammalian cAMP-dependent protein kinase detected by capillary LC-MS and
RT   tandem mass spectrometry.";
RL   Protein Sci. 7:457-469(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-313 (ISOFORM 2), TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RC   STRAIN=Wistar;
RX   PubMed=14514679; DOI=10.1074/jbc.m308365200;
RA   Ullas K.S., Rao M.R.S.;
RT   "Phosphorylation of rat spermatidal protein TP2 by sperm-specific protein
RT   kinase A and modulation of its transport into the haploid nucleus.";
RL   J. Biol. Chem. 278:52673-52680(2003).
RN   [4]
RP   FUNCTION IN RAPID EYE MOVEMENT SLEEP.
RX   PubMed=20844122; DOI=10.1523/jneurosci.1563-10.2010;
RA   Datta S., Desarnaud F.;
RT   "Protein kinase A in the pedunculopontine tegmental nucleus of rat
RT   contributes to regulation of rapid eye movement sleep.";
RL   J. Neurosci. 30:12263-12273(2010).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [6]
RP   INTERACTION WITH RAB13.
RX   PubMed=23419316; DOI=10.1530/jme-13-0011;
RA   Su W., Liu X.;
RT   "RAB13 regulates Sertoli cell permeability barrier dynamics through protein
RT   kinase A.";
RL   J. Mol. Endocrinol. 50:305-318(2013).
CC   -!- FUNCTION: Phosphorylates a large number of substrates in the cytoplasm
CC       and the nucleus (By similarity). Phosphorylates CDC25B, ABL1, NFKB1,
CC       CLDN3, PSMC5/RPT6, PJA2, RYR2, RORA, SOX9 and VASP (By similarity).
CC       Regulates the abundance of compartmentalized pools of its regulatory
CC       subunits through phosphorylation of PJA2 which binds and ubiquitinates
CC       these subunits, leading to their subsequent proteolysis. RORA is
CC       activated by phosphorylation. Required for glucose-mediated adipogenic
CC       differentiation increase and osteogenic differentiation inhibition from
CC       osteoblasts (By similarity). Involved in chondrogenesis by mediating
CC       phosphorylation of SOX9 (By similarity). Involved in the regulation of
CC       platelets in response to thrombin and collagen; maintains circulating
CC       platelets in a resting state by phosphorylating proteins in numerous
CC       platelet inhibitory pathways when in complex with NF-kappa-B (NFKB1 and
CC       NFKB2) and I-kappa-B-alpha (NFKBIA), but thrombin and collagen disrupt
CC       these complexes and free active PRKACA stimulates platelets and leads
CC       to platelet aggregation by phosphorylating VASP. RYR2 channel activity
CC       is potentiated by phosphorylation in presence of luminal Ca(2+),
CC       leading to reduced amplitude and increased frequency of store overload-
CC       induced Ca(2+) release (SOICR) characterized by an increased rate of
CC       Ca(2+) release and propagation velocity of spontaneous Ca(2+) waves,
CC       despite reduced wave amplitude and resting cytosolic Ca(2+). PSMC5/RPT6
CC       activation by phosphorylation stimulates proteasome. Negatively
CC       regulates tight junctions (TJs) in ovarian cancer cells via CLDN3
CC       phosphorylation. NFKB1 phosphorylation promotes NF-kappa-B p50-p50 DNA
CC       binding. Required for phosphorylation of GLI transcription factors
CC       which inhibits them and prevents transcriptional activation of Hedgehog
CC       signaling pathway target genes (By similarity). GLI transcription
CC       factor phosphorylation is inhibited by interaction of PRKACA with SMO
CC       which sequesters PRKACA at the cell membrane (By similarity). Involved
CC       in embryonic development by down-regulating the Hedgehog (Hh) signaling
CC       pathway that determines embryo pattern formation and morphogenesis most
CC       probably through the regulation of OFD1 in ciliogenesis (By
CC       similarity). Prevents meiosis resumption in prophase-arrested oocytes
CC       via CDC25B inactivation by phosphorylation (By similarity). May also
CC       regulate rapid eye movement (REM) sleep in the pedunculopontine
CC       tegmental (PPT) (PubMed:20844122). Phosphorylates APOBEC3G and AICDA.
CC       Phosphorylates HSF1; this phosphorylation promotes HSF1 nuclear
CC       localization and transcriptional activity upon heat shock (By
CC       similarity). Acts as a negative regulator of mTORC1 by mediating
CC       phosphorylation of RPTOR (By similarity).
CC       {ECO:0000250|UniProtKB:P05132, ECO:0000250|UniProtKB:P17612,
CC       ECO:0000269|PubMed:20844122}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.11;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.11;
CC   -!- ACTIVITY REGULATION: Allosterically activated by various compounds,
CC       including ATP. Activated by cAMP; the nucleotide acts as a dynamic and
CC       allosteric activator by coupling the two lobes of apo PKA, enhancing
CC       the enzyme dynamics synchronously and priming it for catalysis.
CC   -!- SUBUNIT: A number of inactive tetrameric holoenzymes are produced by
CC       the combination of homo- or heterodimers of the different regulatory
CC       subunits associated with two catalytic subunits. cAMP causes the
CC       dissociation of the inactive holoenzyme into a dimer of regulatory
CC       subunits bound to four cAMP and two free monomeric catalytic subunits.
CC       The cAMP-dependent protein kinase catalytic subunit binds PJA2. Both
CC       isoforms 1 and 2 forms activate cAMP-sensitive PKAI and PKAII
CC       holoenzymes by interacting with regulatory subunit (R) of PKA,
CC       PRKAR1A/PKR1 and PRKAR2A/PKR2, respectively. Interacts with NFKB1,
CC       NFKB2 and NFKBIA in platelets; these interactions are disrupted by
CC       thrombin and collagen. Binds to ABL1 in spermatozoa and with CDC25B in
CC       oocytes (By similarity). Interacts with APOBEC3G and AICDA (By
CC       similarity). Interacts with RAB13; downstream effector of RAB13
CC       involved in tight junction assembly. Found in a complex at least
CC       composed of MROH2B, PRKACA isoform 2 and TCP11 (By similarity).
CC       Interacts with MROH2B (By similarity). Interacts with HSF1 (By
CC       similarity). Isoform 2 interacts with TCP11 (By similarity). Interacts
CC       with TBC1D31; in the regulation of OFD1 (By similarity). Interacts in
CC       free form with SMO (via C-terminus); the interaction leads to
CC       sequestration of PRKACA at the membrane, preventing PRKACA-mediated
CC       phosphorylation of GLI transcription factors (By similarity).
CC       {ECO:0000250|UniProtKB:P05132, ECO:0000250|UniProtKB:P17612,
CC       ECO:0000269|PubMed:23419316}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P17612}. Cell
CC       membrane {ECO:0000250|UniProtKB:P17612}. Membrane
CC       {ECO:0000250|UniProtKB:P17612}; Lipid-anchor
CC       {ECO:0000250|UniProtKB:P17612}. Nucleus {ECO:0000250|UniProtKB:P17612}.
CC       Mitochondrion {ECO:0000250|UniProtKB:P05132}. Note=Translocates into
CC       the nucleus (monomeric catalytic subunit). The inactive holoenzyme is
CC       found in the cytoplasm. Distributed throughout the cytoplasm in
CC       meiotically incompetent oocytes. Associated to mitochondrion as meiotic
CC       competence is acquired. Aggregates around the germinal vesicles (GV) at
CC       the immature GV stage oocytes (By similarity). Colocalizes with HSF1 in
CC       nuclear stress bodies (nSBs) upon heat shock (By similarity). Recruited
CC       to the cell membrane through interaction with SMO (By similarity).
CC       {ECO:0000250|UniProtKB:P05132, ECO:0000250|UniProtKB:P17612}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cell projection, cilium, flagellum
CC       {ECO:0000250|UniProtKB:P05132}. Cytoplasmic vesicle, secretory vesicle,
CC       acrosome {ECO:0000250|UniProtKB:P05132}. Note=Expressed in the midpiece
CC       region of the sperm flagellum. Expressed in the midpiece region of the
CC       sperm flagellum. Colocalizes with MROH2B and TCP11 on the acrosome and
CC       tail regions in round spermatids and spermatozoa regardless of the
CC       capacitation status of the sperm. {ECO:0000250,
CC       ECO:0000250|UniProtKB:P05132}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=C-alpha-1;
CC         IsoId=P27791-1; Sequence=Displayed;
CC       Name=2; Synonyms=Cs;
CC         IsoId=P27791-2; Sequence=VSP_013277;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Isoform 2 is round
CC       spermatid specific. {ECO:0000269|PubMed:14514679,
CC       ECO:0000269|PubMed:1711374}.
CC   -!- DEVELOPMENTAL STAGE: In spermatids, isoform 1 is expressed until
CC       spermatids become elutriated, whereafter isoform 2 is expressed.
CC       {ECO:0000269|PubMed:14514679}.
CC   -!- PTM: Asn-3 is deaminated to Asp in more than 25% of the proteins,
CC       giving rise to 2 major isoelectric variants, called CB and CA
CC       respectively (0.4 pH unit change). Deamidation proceeds via the so-
CC       called beta-aspartyl shift mechanism and yields either 'D-Asp-2'
CC       (major) or 'D-isoAsp-2' (minor), in addition to L-isomers. Deamidation
CC       occurs after the addition of myristate. The Asn-3 form reaches a
CC       significantly larger nuclear/cytoplasmic ratio than the 'Asp-2' form.
CC       {ECO:0000269|PubMed:9521123}.
CC   -!- PTM: Autophosphorylated. Phosphorylation is enhanced by vitamin K(2).
CC       Phosphorylated on threonine and serine residues. Phosphorylation on
CC       Thr-198 is required for full activity (By similarity). Phosphorylated
CC       at Tyr-331 by activated receptor tyrosine kinases EGFR and PDGFR; this
CC       increases catalytic efficiency (By similarity).
CC       {ECO:0000250|UniProtKB:P05132, ECO:0000250|UniProtKB:P17612}.
CC   -!- PTM: When myristoylated, Ser-11 is autophosphorylated probably in
CC       conjunction with deamidation of Asn-3. {ECO:0000250|UniProtKB:P05132}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. cAMP subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X57986; CAA41052.1; -; mRNA.
DR   EMBL; AY375243; AAQ81631.1; -; mRNA.
DR   PIR; S16240; OKRT2C.
DR   AlphaFoldDB; P27791; -.
DR   BMRB; P27791; -.
DR   SMR; P27791; -.
DR   CORUM; P27791; -.
DR   DIP; DIP-37312N; -.
DR   IntAct; P27791; 5.
DR   MINT; P27791; -.
DR   STRING; 10116.ENSRNOP00000044732; -.
DR   BindingDB; P27791; -.
DR   ChEMBL; CHEMBL3390; -.
DR   GuidetoPHARMACOLOGY; 1476; -.
DR   iPTMnet; P27791; -.
DR   PhosphoSitePlus; P27791; -.
DR   jPOST; P27791; -.
DR   PaxDb; 10116-ENSRNOP00000044732; -.
DR   AGR; RGD:3389; -.
DR   RGD; 3389; Prkaca.
DR   eggNOG; KOG0616; Eukaryota.
DR   InParanoid; P27791; -.
DR   PhylomeDB; P27791; -.
DR   BRENDA; 2.7.11.11; 5301.
DR   Reactome; R-RNO-163615; PKA activation.
DR   Reactome; R-RNO-164378; PKA activation in glucagon signalling.
DR   Reactome; R-RNO-180024; DARPP-32 events.
DR   Reactome; R-RNO-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-RNO-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-RNO-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-RNO-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-RNO-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-RNO-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   Reactome; R-RNO-392517; Rap1 signalling.
DR   Reactome; R-RNO-422356; Regulation of insulin secretion.
DR   Reactome; R-RNO-432040; Vasopressin regulates renal water homeostasis via Aquaporins.
DR   Reactome; R-RNO-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-RNO-442720; CREB1 phosphorylation through the activation of Adenylate Cyclase.
DR   Reactome; R-RNO-512988; Interleukin-3, Interleukin-5 and GM-CSF signaling.
DR   Reactome; R-RNO-5578775; Ion homeostasis.
DR   Reactome; R-RNO-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-RNO-5610787; Hedgehog 'off' state.
DR   Reactome; R-RNO-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-RNO-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-RNO-8853659; RET signaling.
DR   Reactome; R-RNO-8854518; AURKA Activation by TPX2.
DR   Reactome; R-RNO-8963896; HDL assembly.
DR   Reactome; R-RNO-9634597; GPER1 signaling.
DR   Reactome; R-RNO-983231; Factors involved in megakaryocyte development and platelet production.
DR   Reactome; R-RNO-9837999; Mitochondrial protein degradation.
DR   EvolutionaryTrace; P27791; -.
DR   PRO; PR:P27791; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0001669; C:acrosomal vesicle; ISS:UniProtKB.
DR   GO; GO:0005930; C:axoneme; ISO:RGD.
DR   GO; GO:0005952; C:cAMP-dependent protein kinase complex; IDA:RGD.
DR   GO; GO:0005813; C:centrosome; ISO:RGD.
DR   GO; GO:0097546; C:ciliary base; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0043197; C:dendritic spine; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:SynGO.
DR   GO; GO:0016607; C:nuclear speck; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0031588; C:nucleotide-activated protein kinase complex; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0044853; C:plasma membrane raft; ISO:RGD.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0098793; C:presynapse; IDA:SynGO.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0036126; C:sperm flagellum; ISS:UniProtKB.
DR   GO; GO:0097225; C:sperm midpiece; ISS:UniProtKB.
DR   GO; GO:0004679; F:AMP-activated protein kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0005524; F:ATP binding; ISO:RGD.
DR   GO; GO:0004691; F:cAMP-dependent protein kinase activity; IDA:RGD.
DR   GO; GO:0000287; F:magnesium ion binding; ISO:RGD.
DR   GO; GO:0030145; F:manganese ion binding; ISO:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0034237; F:protein kinase A regulatory subunit binding; ISO:RGD.
DR   GO; GO:0004672; F:protein kinase activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:BHF-UCL.
DR   GO; GO:0106310; F:protein serine kinase activity; ISO:RGD.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0031267; F:small GTPase binding; IPI:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0141156; P:cAMP/PKA signal transduction; ISO:RGD.
DR   GO; GO:0070417; P:cellular response to cold; ISO:RGD.
DR   GO; GO:0071377; P:cellular response to glucagon stimulus; ISO:RGD.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; ISO:RGD.
DR   GO; GO:0034605; P:cellular response to heat; ISS:UniProtKB.
DR   GO; GO:0071374; P:cellular response to parathyroid hormone stimulus; ISO:RGD.
DR   GO; GO:0001707; P:mesoderm formation; ISO:RGD.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0006397; P:mRNA processing; ISO:RGD.
DR   GO; GO:1904539; P:negative regulation of glycolytic process through fructose-6-phosphate; ISO:RGD.
DR   GO; GO:0051447; P:negative regulation of meiotic cell cycle; IDA:RGD.
DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; ISO:RGD.
DR   GO; GO:1904262; P:negative regulation of TORC1 signaling; ISS:UniProtKB.
DR   GO; GO:0001843; P:neural tube closure; ISO:RGD.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IMP:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0045722; P:positive regulation of gluconeogenesis; ISO:RGD.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; ISO:RGD.
DR   GO; GO:0046827; P:positive regulation of protein export from nucleus; ISO:RGD.
DR   GO; GO:0099170; P:postsynaptic modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0006611; P:protein export from nucleus; ISO:RGD.
DR   GO; GO:0010737; P:protein kinase A signaling; IBA:GO_Central.
DR   GO; GO:1990044; P:protein localization to lipid droplet; ISO:RGD.
DR   GO; GO:2000810; P:regulation of bicellular tight junction assembly; ISO:RGD.
DR   GO; GO:0051726; P:regulation of cell cycle; ISO:RGD.
DR   GO; GO:0043457; P:regulation of cellular respiration; IDA:RGD.
DR   GO; GO:0045667; P:regulation of osteoblast differentiation; ISO:RGD.
DR   GO; GO:0061136; P:regulation of proteasomal protein catabolic process; ISO:RGD.
DR   GO; GO:0070613; P:regulation of protein processing; ISO:RGD.
DR   GO; GO:0051966; P:regulation of synaptic transmission, glutamatergic; IDA:RGD.
DR   GO; GO:0048240; P:sperm capacitation; ISO:RGD.
DR   GO; GO:0048792; P:spontaneous exocytosis of neurotransmitter; IMP:UniProtKB.
DR   CDD; cd14209; STKc_PKA; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR044109; STKc_PKA.
DR   PANTHER; PTHR24353:SF82; CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA; 1.
DR   PANTHER; PTHR24353; CYCLIC NUCLEOTIDE-DEPENDENT PROTEIN KINASE; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; cAMP; Cell membrane; Cell projection;
KW   Cilium; Cytoplasm; Cytoplasmic vesicle; Direct protein sequencing;
KW   Flagellum; Kinase; Lipoprotein; Membrane; Mitochondrion; Myristate;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:9521123"
FT   CHAIN           2..351
FT                   /note="cAMP-dependent protein kinase catalytic subunit
FT                   alpha"
FT                   /id="PRO_0000086055"
FT   DOMAIN          44..298
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          299..351
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   ACT_SITE        167
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         50..58
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         73
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         122..128
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         169..172
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         3
FT                   /note="Deamidated asparagine; partial"
FT                   /evidence="ECO:0000269|PubMed:9521123"
FT   MOD_RES         11
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P05132"
FT   MOD_RES         49
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P17612"
FT   MOD_RES         140
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P05132"
FT   MOD_RES         196
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P17612"
FT   MOD_RES         198
FT                   /note="Phosphothreonine; by PDPK1"
FT                   /evidence="ECO:0000250|UniProtKB:P00517"
FT   MOD_RES         331
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P05132"
FT   MOD_RES         339
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000269|PubMed:9521123"
FT   VAR_SEQ         1..15
FT                   /note="MGNAAAAKKGSEQES -> MASNSND (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14514679"
FT                   /id="VSP_013277"
SQ   SEQUENCE   351 AA;  40620 MW;  4763ACD074AB2384 CRC64;
     MGNAAAAKKG SEQESVKEFL AKAKEDFLKK WEDPSQNTAQ LDHFDRIKTL GTGSFGRVML
     VKHKESGNHY AMKILDKQKV VKLKQIEHTL NEKRILQAVN FPFLVKLEFS FKDNSNLYMV
     MEYVPGGEMF SHLRRIGRFS EPHARFYAAQ IVLTFEYLHS LDLIYRDLKP ENLLIDQQGY
     IQVTDFGFAK RVKGRTWTLC GTPEYLAPEI ILSKGYNKAV DWWALGVLIY EMAAGYPPFF
     ADQPIQIYEK IVSGKVRFPS HFSSDLKDLL RNLLQVDLTK RFGNLKNGVN DIKNHKWFAT
     TDWIAIYQRK VEAPFIPKFK GPGDTSNFDD YEEEEIRVSI NEKCGKEFTE F
//
